Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

Articles published in
Infect Immun
    October 2026
  1. DE PASCALIS R, Espich S, Khan H, Toney M, et al
    Erratum for De Pascalis et al., "Transcriptional analyses of peripheral blood lymphocytes obtained shortly after primary immunization discriminate vaccines against Francisella tularensis".
    Infect Immun. 2026 Oct 8:e0051626. doi: 10.1128/iai.00516.
    >> Share

  2. MILLER JM, Mara AB, Ozyck RG, Savoie R, et al
    Immune responses induced by a subunit vaccine against Mycoplasma gallisepticum.
    Infect Immun. 2026 Oct 7:e0030526. doi: 10.1128/iai.00305.
    >> Share

    September 2026
  3. MAITI S, Lu T, Dietz ZK, Whittier SK, et al
    An intranasal bivalent vaccine induces antigen-specific humoral and Th1/Th17 cellular immunity and protects young and aged mice against MRSA and Pseudomonas aeruginosa skin and soft tissue infections.
    Infect Immun. 2026 Sep 24:e0035526. doi: 10.1128/iai.00355.
    >> Share

    August 2026
  4. DE PASCALIS R, Espich S, Khan H, Toney M, et al
    Transcriptional analyses of peripheral blood lymphocytes obtained shortly after primary immunization discriminate vaccines against Francisella tularensis.
    Infect Immun. 2026 Aug 14:e0020826. doi: 10.1128/iai.00208.
    >> Share

  5. HOWLADER DR, Das S, Biswas S, Dietz ZK, et al
    A multivalent subunit vaccine augments pre-existing immunity to protect against T3SS-positive Pseudomonas aeruginosa but reveals immunological interference against ExlA-positive strains.
    Infect Immun. 2026 Aug 4:e0017526. doi: 10.1128/iai.00175.
    >> Share

    July 2026
  6. KUMARESAN V, Smith TC 2nd, Lumbreras M, MacMackin Ingle T, et al
    Protective efficacy of mutant strains of Borrelia burgdorferi as potential reservoir host-targeted biologics against Lyme disease.
    Infect Immun. 2026;94:e0021026.
    >> Share

  7. LIM PS, Bernal J, Karunarathne J, Longley RJ, et al
    Malaria serology for surveillance, insights into immunity, and vaccine development.
    Infect Immun. 2026 Jul 13:e0003126. doi: 10.1128/iai.00031.
    >> Share

    June 2026
  8. MILLER JM, Ozyck RG, Mara AB, Hernandez EF, et al
    Recombinant subunit vaccine against Mycoplasma gallisepticum disease confers cross-protection against multiple pathogenic strains.
    Infect Immun. 2026 Jun 12:e0002526. doi: 10.1128/iai.00025.
    >> Share

    May 2026
  9. BHATTACHARYYA A, Mantis NJ
    OspA antibodies inhibit the in vitro transmigration of Borrelia burgdorferi.
    Infect Immun. 2026;94:e0012826.
    >> Share

    April 2026
  10. GARNICA O, Veerapandian R, Das K, Mishra A, et al
    Construction and characterization of novel Mycobacterium tuberculosis-derived triple and quadruple knockout vaccines against tuberculosis.
    Infect Immun. 2026 Apr 21:e0050025. doi: 10.1128/iai.00500.
    >> Share

  11. LIU Z, Li C, Mahan S, Ren J, et al
    The oral vaccine intrOv is attenuated in infecting the lower airway and inducing chronic pathology.
    Infect Immun. 2026 Apr 15:e0012226. doi: 10.1128/iai.00122.
    >> Share

    March 2026
  12. THAYER TC, Cox A, Gonzalez E, Mangiafesto J, et al
    Lipidated Protein D vaccination elicits humoral and cellular responses and protects mice against challenge with non-typeable Haemophilus influenzae.
    Infect Immun. 2026 Mar 31:e0064725. doi: 10.1128/iai.00647.
    >> Share

    January 2026
  13. MASTROENI P, Rossi O, Micoli F
    Multivalent vaccines for invasive Salmonella disease: need, rationale, and immunological foundations.
    Infect Immun. 2026 Jan 6:e0011825. doi: 10.1128/iai.00118.
    >> Share

    December 2025
  14. ZHU Z, Xu J, Yang J, Tian H, et al
    Klebsiella pneumoniae ghosts as a novel adjuvant drive dendritic cell maturation and antigen-specific TCM expansion for IFN-gamma-mediated immune protection.
    Infect Immun. 2025;93:e0033525.
    >> Share

    November 2025
  15. AVINA SL, Pawar S, Kadam RN, Rivera A, et al
    Mannoprotein Cig1 contributes to the immunogenicity of a heat-killed F-box protein Fbp1 Cryptococcus neoformans vaccine model.
    Infect Immun. 2025 Nov 28:e0035525. doi: 10.1128/iai.00355.
    >> Share

  16. KAWASHIMA S, Takahashi K, Yanagisawa D, Irikura C, et al
    Immunogenicity and plasmid delivery pathways of non-invasive Lactococcus lactis-vectored mucosal DNA vaccination.
    Infect Immun. 2025 Nov 28:e0046025. doi: 10.1128/iai.00460.
    >> Share

  17. ZHANG W, Sack DA
    Recent progress in enterotoxigenic Escherichia coli vaccine research and development.
    Infect Immun. 2025 Nov 6:e0036825. doi: 10.1128/iai.00368.
    >> Share

  18. HEINZEN RA, Pierce KN, Voth DE, Stenos J, et al
    Control of human Q fever by vaccination: the journey to Q-VAX and beyond.
    Infect Immun. 2025 Nov 6:e0028025. doi: 10.1128/iai.00280.
    >> Share

    October 2025
  19. LATRE DE LATE P, Stoll IM, Ferm J, Madesh S, et al
    Rickettsia rickettsii inactivated whole cell antigen vaccine protects against Rocky Mountain spotted fever independent of the adjuvant used.
    Infect Immun. 2025 Oct 29:e0041225. doi: 10.1128/iai.00412.
    >> Share

    September 2025
  20. LIU T, Zhao H, Wu Q, Wei Y, et al
    Evaluation of Mycoplasma mycoides subsp. mycoides antigens capable of stimulating host IRG-47 release identifies Mmm604, Mmm605, and Mmm606 as potential subunit vaccine antigens.
    Infect Immun. 2025 Sep 9:e0018625. doi: 10.1128/iai.00186.
    >> Share

    July 2025
  21. BHIMANI S, Ferraro MJ
    Reply to Babich, "Using exosomes for universal vaccines".
    Infect Immun. 2025 Jul 9:e0020725. doi: 10.1128/iai.00207.
    >> Share

  22. BABICH AR
    Using exosomes for universal vaccines.
    Infect Immun. 2025 Jul 9:e0012925. doi: 10.1128/iai.00129.
    >> Share

    May 2025
  23. AZEVEDO JF, Joyner G, Kundu S, Samanta K, et al
    Maternal transfer of oral vaccine induced anti-OspA antibodies protects Peromyscus spp. from tick-transmitted Borrelia burgdorferi.
    Infect Immun. 2025 May 19:e0021625. doi: 10.1128/iai.00216.
    >> Share

  24. VICKERS TJ, Buckley DP, Khatoon N, Sheikh A, et al
    Parenteral vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization.
    Infect Immun. 2025 May 1:e0060124. doi: 10.1128/iai.00601.
    >> Share

    April 2025
  25. LI S, Upadhyay I, Seo H, Vakamalla SSR, et al
    Immunogenicity and preclinical efficacy characterization of ShecVax, a combined vaccine against Shigella and enterotoxigenic Escherichia coli.
    Infect Immun. 2025 Apr 10:e0000425. doi: 10.1128/iai.00004.
    >> Share

    March 2025
  26. ZHANG C, Li S, Upadhyay I, Vakamalla SSR, et al
    Heterologous prime-boost immunization of two-component vaccine candidate PWDVax protected pigs against F18 enterotoxigenic Escherichia coli post-weaning diarrhea.
    Infect Immun. 2025 Mar 12:e0040624. doi: 10.1128/iai.00406.
    >> Share

    February 2025
  27. PEREIRA IL, Hartwig DD
    Unveiling the role of adhesin proteins in controlling Acinetobacter baumannii infections: a systematic review.
    Infect Immun. 2025;93:e0034824.
    >> Share

    January 2025

  28. Expression of Concern for Teixeira et al., "Immunogenicity of a Prime-Boost Vaccine Containing the Circumsporozoite Proteins of Plasmodium vivax in Rodents".
    Infect Immun. 2025 Jan 13:e0054424. doi: 10.1128/iai.00544.
    >> Share

  29. EMERSON LE, Bhimani S, Rainey AL, Maurelli AT, et al
    Evaluating small extracellular vesicle-based vaccination across heterologous Salmonella strains isolated from wastewater.
    Infect Immun. 2025 Jan 13:e0048524. doi: 10.1128/iai.00485.
    >> Share

    December 2024
  30. HALDAR R, Halder P, Koley H, Miyoshi S-i, et al
    A newly developed oral infection mouse model of shigellosis for immunogenicity and protective efficacy studies of a candidate vaccine.
    Infect Immun. 2024 Dec 18:e0034624. doi: 10.1128/iai.00346.
    >> Share

    November 2024
  31. CHAMBERS GZ, Chambers KMF, Marconi RT
    A single immunization of Borreliella burgdorferi-infected mice with Vanguard crLyme elicits robust antibody responses to diverse strains and variants of outer surface protein C.
    Infect Immun. 2024;92:e0039624.
    >> Share

    October 2024
  32. FRATZKE AP, Szule JA, Butler SM, Schaik EJv, et al
    Molecular mechanisms of Coxiella burnetii formalin-fixed cellular vaccine reactogenicity.
    Infect Immun. 2024 Oct 2:e0033524. doi: 10.1128/iai.00335.
    >> Share

    September 2024
  33. CHORRO L, Ciolino T, Torres CL, Illenberger A, et al
    A cynomolgus monkey E. coli urinary tract infection model confirms efficacy of new FimH vaccine candidates.
    Infect Immun. 2024 Sep 19:e0016924. doi: 10.1128/iai.00169.
    >> Share

    August 2024
  34. PYLES GM, Huckaby AB, Gutierrez MdlP, Witt WT, et al
    Virus-like particles displaying the mature C-terminal domain of filamentous hemagglutinin are immunogenic and protective against Bordetella pertussis respiratory infection in mice.
    Infect Immun. 2024;92:e0027024.
    >> Share

    July 2024
  35. BITZER GJ, Fitzgerald NA, DeJong MA, Cunningham C, et al
    Immunization with an mRNA DTP vaccine protects against pertussis in rats.
    Infect Immun. 2024 Jul 17:e0052023. doi: 10.1128/iai.00520.
    >> Share

    June 2024
  36. OSTAPCHUK YO, Lushova AV, Kan SA, Abdolla N, et al
    Long-term changes in the phenotype and cytokine production of monocytes in COVID-19 recovered and vaccinated individuals.
    Infect Immun. 2024 Jun 14:e0021624. doi: 10.1128/iai.00216.
    >> Share

    May 2024
  37. IHARA S, Nguyen BV, Miyamoto Y, Eckmann L, et al
    Mucosal vaccination in a murine gnotobiotic model of Giardia lamblia infection.
    Infect Immun. 2024 May 9:e0006524. doi: 10.1128/iai.00065.
    >> Share

    April 2024
  38. XING Y, Clark JR, Chang JD, Zulk JJ, et al
    Progress toward a vaccine for extraintestinal pathogenic E. coli (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approach.
    Infect Immun. 2024 Apr 9:e0044023. doi: 10.1128/iai.00440.
    >> Share

    March 2024
  39. VANCE DJ, Basir S, Piazza CL, Willsey GG, et al
    Single-domain antibodies reveal unique borrelicidal epitopes on the Lyme disease vaccine antigen, outer surface protein A (OspA).
    Infect Immun. 2024 Mar 12:e0008424. doi: 10.1128/iai.00084.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016